AIMEDIC 로고 이미지
모바일 메뉴 닫기
About AIMEDIC
모바일 서브 메뉴 닫기
Our Story
Our History
Products
모바일 서브 메뉴 닫기
HeartMedi+
AutoSeg
AngioFFR
CardioLucid
Publications
모바일 서브 메뉴 닫기
News
모바일 서브 메뉴 닫기
Contact us
모바일 서브 메뉴 닫기
혁신의료기술
모바일 서브 메뉴 닫기
실시기관
이용안내
논문 목록으로

AIMEDIC 논문

Functional recombinants designed from a fetuin/asialofetuin-specific marine algal lectin, rhodobindin

분류
Pub
일자
2015-04-13
출처
Marine drugs

Plant lectins have attracted much attention for biomedical applications including targeted drug delivery system and therapy against tumors and microbial infections. The main problem of using lectins as a biomedical tool is a batch-to-batch variation in isoforms content. The production of lectins using recombination tools has the advantage of obtaining high amounts of proteins with more precise properties, but there are only a handful of functional recombinant lectins presently available. A fetuin/asialo-fetuin specific lectin, Rhodobindin, has unique tandem repeats structure which makes it useful in exploiting for recombinant lectin. We developed three functional recombinant lectins using E. coli expression system: one from full cDNA sequence and two from fragmentary sequences of Rhodobindin. Hemagglutinating activity and solubility of the recombinant lectins were highest at OD 0.7 cell concentration at 20 °C. The optimized process developed in this study was suitable for the quality-controlled production of high amounts of soluble recombinant lectins.

콘텐츠 업데이트: API 게시 일자를 우선 사용합니다. 연구 초록과 원문 링크, 제품 페이지의 사용 목적 및 제한사항을 함께 확인하세요.

맨 위로 이동